01 4Qvar
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 250
2018 Revenue in Millions : 182
Growth (%) : 37
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 179
2019 Revenue in Millions : 250
Growth (%) : -28
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2021 Revenue in Millions : 0
2020 Revenue in Millions : 179
Growth (%) : -100
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 182
2017 Revenue in Millions : 313
Growth (%) : -42%
LOOKING FOR A SUPPLIER?